Fox Run Management’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,648
Closed -$209K 343
2020
Q4
$209K Buy
+2,648
New +$155K 0.42% 134
2017
Q4
Sell
-2,900
Closed -$273K 964
2017
Q3
$273K Buy
+2,900
New +$229K 0.08% 526
2016
Q4
Sell
-4,000
Closed -$312K 739
2016
Q3
$312K Buy
+4,000
New +$290K 0.18% 239

Other funds holding CMD

Fox Run Management's CMD Position: Q1 2021 in Review

Fox Run Management sold out of Cantel Medical Corporation (CMD) in Q1 2021, closing a stake of 2,648 shares — an estimated $209K sold.

Fox Run Management first reported a position in CMD in Q3 2016 and held it in 3 quarters. The position peaked at $312K in Q3 2016. 234 funds tracked by Wall St. Rank hold CMD as of Q1 2021.

  • Fox Run Management reported no remaining Cantel Medical Corporation position as of Q1 2021 after selling out during the quarter.
  • Fox Run Management sold 2,648 Cantel Medical Corporation shares in Q1 2021, an estimated $209K.
  • Fox Run Management first reported a position in Cantel Medical Corporation in Q3 2016 and held it in 3 quarters.
  • Fox Run Management's Cantel Medical Corporation position peaked at $312K in Q3 2016.
  • 234 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2021.

Based on Fox Run Management's 13F filing for Q1 2021, filed 17 May 2021.